Literature DB >> 18496346

Adjacent segment degeneration: observations in a goat spinal fusion study.

Roel J W Hoogendoorn1, Macro N Helder, Paul I J M Wuisman, Ruud A Bank, Vincent E Everts, Theo H Smit.   

Abstract

STUDY
DESIGN: The adjacent discs of 13 goats, originally used in a lumbar spinal fusion model study, were analyzed for symptoms of intervertebral disc degeneration by means of magnetic resonance imaging (MRI), macroscopy, and histology. These goats were followed for 6 months and the results were compared with 6 control goats.
OBJECTIVE: To evaluate the development of adjacent segment disc degeneration in vivo in a goat lumbar spinal fusion model. SUMMARY OF BACKGROUND DATA: There is ongoing debate on whether adjacent segment degeneration (ASD) develops through increased biomechanical load on discs adjacent to fusion sites, or by the natural process of pre-existing degenerative disease. Animal models offer an opportunity to separate these factors by evaluating the development of ASD in nondegenerated animal spines.
METHODS: In a spinal fusion model study 2 segments (L3-L4 and L1-L2) were fixated and followed for 3 months (n = 6) and 6 months (n = 7) in 13 skeletally mature goats. Two adjacent discs (T13-L1 and L4-L5), 1 interjacent disc (L2-L3) and a control disc (L5-L6) were analyzed by means of magnetic resonance imaging, macroscopy, and histology. These results were compared with the discs of 6, nonoperated "normal" goats.
RESULTS: No differences were observed in the adjacent and interjacent intervertebral discs after both follow-up periods. However, severe degenerative changes were observed in the L5-L6 level, originally included as controls.
CONCLUSION: Large animal fusion models offer an excellent opportunity to study ASD in vivo, as pre-existing degenerative disc disease is not present and biomechanical effects of the fusion can be studied more isolated. Our results suggest that adjacent disc degeneration does not develop in our spinal goat fusion model. There is, however, an increased risk of disc degeneration in the L5-L6 level through an unclear mechanism.

Entities:  

Mesh:

Year:  2008        PMID: 18496346     DOI: 10.1097/BRS.0b013e318173438f

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  7 in total

Review 1.  Limitations of current in vitro test protocols for investigation of instrumented adjacent segment biomechanics: critical analysis of the literature.

Authors:  David Volkheimer; Masoud Malakoutian; Thomas R Oxland; Hans-Joachim Wilke
Journal:  Eur Spine J       Date:  2015-06-03       Impact factor: 3.134

2.  [Adjacent segment degeneration following spinal fusion of vertebral fractures in paraplegic patients].

Authors:  L Homagk; J Henneberger; G O Hofmann
Journal:  Chirurg       Date:  2019-11       Impact factor: 0.955

3.  Recurrent adjacent segment disease and cauda equina syndrome.

Authors:  Xavier Conesa; Ferran Pellisé; Susana Núñez; Carlos Villanueva; Enric Cáceres
Journal:  Eur Spine J       Date:  2010-12-30       Impact factor: 3.134

4.  Relation between radiological assessment and biomechanical stability of lumbar interbody fusion in a large animal model.

Authors:  R J Kroeze; A J van der Veen; B J van Royen; R A Bank; M N Helder; T H Smit
Journal:  Eur Spine J       Date:  2013-09-17       Impact factor: 3.134

5.  Lumbar intervertebral disc allograft transplantation: long-term mobility and impact on the adjacent segments.

Authors:  Yong-Can Huang; Jun Xiao; William W Lu; Victor Y L Leung; Yong Hu; Keith D K Luk
Journal:  Eur Spine J       Date:  2016-03-23       Impact factor: 3.134

6.  Survival and prognostic analysis of adjacent segments after spinal fusion.

Authors:  Dong Ki Ahn; Hoon Seok Park; Dae Jung Choi; Kwan Soo Kim; Seung Jin Yang
Journal:  Clin Orthop Surg       Date:  2010-08-03

7.  Evidence-Based Analysis of Adjacent Segment Degeneration and Disease After LIF: A Narrative Review.

Authors:  Nikunj N Trivedi; Sean M Wilson; Luis A Puchi; Darren R Lebl
Journal:  Global Spine J       Date:  2018-02-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.